Share on StockTwits

Dolby Laboratories (NYSE:DLB) was upgraded by Zacks from a “neutral” rating to an “outperform” rating in a research report issued on Tuesday. The firm currently has a $46.00 price target on the stock. Zacks‘s price target suggests a potential upside of 5.46% from the stock’s previous close.

A number of other firms have also recently commented on DLB. Analysts at B. Riley initiated coverage on shares of Dolby Laboratories in a research note on Tuesday. They set a “neutral” rating and a $41.00 price target on the stock. Analysts at JPMorgan Chase & Co. reiterated an “underweight” rating on shares of Dolby Laboratories in a research note on Wednesday, April 30th. They now have a $38.00 price target on the stock. One analyst has rated the stock with a sell rating, two have issued a hold rating and two have assigned a buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $41.67.

Dolby Laboratories (NYSE:DLB) traded up 0.97% during mid-day trading on Tuesday, hitting $43.62. The stock had a trading volume of 449,812 shares. Dolby Laboratories has a one year low of $31.00 and a one year high of $45.16. The stock has a 50-day moving average of $41.35 and a 200-day moving average of $41.53. The company has a market cap of $4.474 billion and a P/E ratio of 22.72.

Dolby Laboratories (NYSE:DLB) last announced its earnings results on Tuesday, April 29th. The company reported $0.88 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.50 by $0.38. The company had revenue of $278.60 million for the quarter, compared to the consensus estimate of $244.77 million. During the same quarter in the prior year, the company posted $0.74 earnings per share. The company’s quarterly revenue was up 11.8% on a year-over-year basis. On average, analysts predict that Dolby Laboratories will post $1.76 earnings per share for the current fiscal year.

Dolby Laboratories, Inc develops and delivers products and technologies that are used in the entertainment industry.

To view Zacks’ full report, visit Zacks’ official website.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.